(19)
(11) EP 3 233 112 A2

(12)

(88) Date of publication A3:
11.08.2016

(43) Date of publication:
25.10.2017 Bulletin 2017/43

(21) Application number: 15808213.1

(22) Date of filing: 11.12.2015
(51) International Patent Classification (IPC): 
A61K 39/00(2006.01)
C07K 16/24(2006.01)
A61P 35/00(2006.01)
(86) International application number:
PCT/EP2015/079384
(87) International publication number:
WO 2016/096640 (23.06.2016 Gazette 2016/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 17.12.2014 GB 201422502

(71) Applicant: Cancer Research Technology Limited
London EC1V 4AD (GB)

(72) Inventors:
  • BALKWILL, Frances Rosemary
    London EC1Y 2AN (GB)
  • MCCAFFERTY, John
    Babraham Cambridge CB22 3AT (GB)
  • GRAHAM, Gerard John
    Giffnock Glasgow G46 7AA (GB)
  • VELLATT, Aneesh Karatt
    Comberton Cambridge CB23 7DN (GB)
  • SLAVNY, Peter
    London EC1V 4AD (GB)

(74) Representative: Kiddle, Simon John et al
Mewburn Ellis LLP
City Tower 40 Basinghall Street London EC2V 5DE
City Tower 40 Basinghall Street London EC2V 5DE (GB)

   


(54) ANTI-CXCL12 ANTIBODY MOLECULES AND THEIR USES